Tylenol w/ codeine no. 3 and Head injury - a phase IV clinical study of FDA data

Summary:

Head injury is found among people who take Tylenol w/ codeine no. 3, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Tylenol w/ codeine no. 3 and have Head injury. It is created by eHealthMe based on reports of 4,453 people who have side effects when taking Tylenol w/ codeine no. 3 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

4,453 people reported to have side effects when taking Tylenol w/ codeine no. 3.
Among them, 104 people (2.34%) have Head injury.

What is Tylenol w/ codeine no. 3?

Tylenol w/ codeine no. 3 has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 4,916 Tylenol w/ codeine no. 3 users for its effectiveness, alternative drugs and more.

What is Head injury?

Head injury is found to be associated with 3,479 drugs and 3,021 conditions by eHealthMe.

Number of Tylenol w/ codeine no. 3 and Head injury reports submitted per year:

Could Tylenol w/ codeine no. 3 cause Head injury?

* Approximation only. Some reports may have incomplete information.

Do you take Tylenol w/ codeine no. 3 and have Head injury?

Check whether Head injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Head injury and when was it recovered:

Head injury in Tylenol w/ codeine no. 3

Expand to all the drugs that have ingredients of acetaminophen; codeine phosphate:

Head injury and drugs with ingredients of acetaminophen; codeine phosphate

Alternative drugs to, pros and cons of Tylenol w/ codeine no. 3:

Tylenol w/ codeine no. 3 (4,916 reports)

Common Tylenol w/ codeine no. 3 side effects:

Pain: 456 reports
Breathing difficulty: 406 reports
Fatigue (feeling of tiredness): 380 reports
Headache (pain in head): 357 reports
Stress and anxiety: 340 reports
Weakness: 326 reports

Browse all side effects of Tylenol w/ codeine no. 3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Head injury treatments and more:

Head injury (138,033 reports)

COVID vaccines that are related to Head injury:

Common drugs associated with Head injury:

All the drugs that are associated with Head injury:

Head injury (3,479 drugs)

Common conditions associated with Head injury:

Rheumatoid arthritis: 12,051 reports
Multiple sclerosis: 10,064 reports
High blood pressure: 6,065 reports
Osteoporosis: 6,034 reports
Pain: 5,104 reports
Atrial fibrillation/flutter: 4,430 reports
Depression: 4,421 reports

All the conditions that are associated with Head injury:

Head injury (3,021 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; codeine phosphate (the active ingredients of Tylenol w/ codeine no. 3) and Tylenol w/ codeine no. 3 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.